Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

Cancer cell | Aug 14, 2012

http://www.ncbi.nlm.nih.gov/pubmed/22897849

Recurrent somatic ASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here, we identify that ASXL1 mutations result in loss of polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data, we identify targets of ASXL1 repression, including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the PRC2, and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis.

Pubmed ID: 22897849 RIS Download

Mesh terms: Animals | Cell Line, Tumor | Cell Proliferation | Cell Transformation, Neoplastic | DNA-Binding Proteins | Gene Expression Regulation, Neoplastic | Gene Knockdown Techniques | Gene Silencing | Hematopoietic System | Histones | Homeodomain Proteins | Humans | Leukemia, Myeloid, Acute | Methylation | Mice | Mutation | Myeloid Cells | Polycomb Repressive Complex 2 | Polycomb-Group Proteins | Protein Binding | Repressor Proteins | Transcription Factors | Tumor Suppressor Proteins | Ubiquitin Thiolesterase | Up-Regulation | ras Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: 1K08CA160647-01
  • Agency: NHLBI NIH HHS, Id: 5U01HL100395
  • Agency: NCI NIH HHS, Id: K08 CA160647
  • Agency: NCI NIH HHS, Id: R01 CA105129
  • Agency: NCI NIH HHS, Id: R01 CA169784
  • Agency: NCI NIH HHS, Id: R01 CA173636
  • Agency: NCI NIH HHS, Id: U54 CA143798
  • Agency: Howard Hughes Medical Institute, Id:
  • Agency: Howard Hughes Medical Institute, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.